Honoured with the Biotech Company of the Year award at the Pharma Summit & Awards 2026. Honoured with the Biotech Company of the Year award at the Pharma Summit & Awards 2026.

About Us

Incorporated in 1969 with a vision to serve mankind, J. Mitra & Co. Pvt. Ltd. started this venture to preserve human lives, by promoting healthcare, through technology and innovation.

J. Mitra & Co. Pvt. Ltd, is the pioneer in manufacturing and marketing of IVD test kits in India. It is the tradition of quality and seriousness of purpose that has led to a sterling and harmonious growth of the company and achieved the recognition that extended far beyond its frontiers.

J. Mitra & Co. Pvt Ltd became the first Indian Company to get drug manufacturing licenses for critical tests like HIV, HBV, HCV in rapid and ELISA formats in India. It introduced the technology of differential detection of HIV 1 and HIV 2 in single rapid kit format, a product which still is the market leader after two decades. J. Mitra identifies its success with its customer’s success and commitment to quality.

J. Mitra & Co. Pvt. Ltd. has continuously produced world class IVD products in India. A recent example being Dengue Day 1 test which have achieved no. 1 market share after its launch in 2010. The company manufactures a range of tests for infectious diseases like HIV, HBV, HCV, Dengue, Malaria, Typhoid, Leptospira in rapid and ELISA test formats. The other products include a range of Anti-Sera products and confirmatory tests like Western Blot for HIV.

The company has recently introduced Fluorescence Immunoassay technology for quantitative and qualitative range of tests. The company manufactures HbA1c, Vitamin D, T3, T4, TSH, Dengue IgM, Dengue IgG, PCT, CRP and Dengue NS1 in FIA (Fluorescence immunoassay) range. These tests can be performed on state of the art analyzer called iQuant, developed in partnership with HTIC, IIT Madras.

The company being fully conscious of its responsibility has adopted best industry practices. Its large scale automation not only improves the quality of kits but also meets the bulk requirements of the customers. J. Mitra facility is ISO 9001:2015 & EN ISO 13485:2016.

J.Mitra & Co. Pvt. Ltd. is an organization steeped in legacy of quality, of innovation, and of social consciousness. It is our extensive R&D that has placed us in the forefront of the IVD industry globally, and it is because of these R&D efforts that we have more than 55 patents more than any other single company in the country.

Milestones

Achievements

1969

Incorporation of the company at New Rajendra Nagar as J.Mitra Bros. Pvt. Ltd.

1981

Lab System launched in India

1983

Company shifted from New Rajendra Nagar to Chiranjeev Tower, Nehru Place, New Delhi

1984

Branch Office opened at J.P. Tower, Chennai

1986

Branch Office opened at Mumbai

1987

Blood Grouping Reagents launched; In-house R&D unit recognized by DSIR, Ministry of Science & Technology

1989

Branch Office launched at Kolkata; Monoclonal Blood Grouping Reagents launched

1991

Corporate Office launched at A-180, Okhla Phase-1, New Delhi

1993

Branch Office opened at Bangalore

1995

HIV TRI-DOT (Rapid Screening Test) for AIDS launched in India based on in-house Research and Development; Company name changed to J.Mitra & Co. Ltd.; Branch Office opened at Hyderabad

1997

HIV ELISA Test Kit launched; Hepatitis-B Test Kit launched

1999

HIV W.BLOT Test Kit officially inaugurated by Prime Minister, Mr. Atal Bihari Vajpayee; Branch Office launched at Ahmedabad

2000

HCV Rapid Test & HCV ELISA Tests launched

2001

Hepatitis-B Strip and Card Tests launched; Corporate Office expansion in Okhla Industrial Area, New Delhi

2002

Focus on Infrastructure Information Technology

2003

Development of Therapy Technology Division

2005

First time launch of T.B Antigen Kit; Launch of T.B Antibody Test Kit; ERP Implementation and Launch of Malaria Kit

2006

4th Generation HIV ELISA & Rapid Test

2007

Lepto IgM & IgG antibody Test Kit

2010

Dengue NS1 Ag & Antibody Rapid Test Kit; Chikungunya antibody Test Kit

2011

Typhoid Antibody Test Kit

2016

Launched iQuant Analyzer and Quanti card range of products

2019

Launched Celiac Range and Scrub Typhus Range of Products

2020

Launched Covid-19 Antibody detection kits based on ELISA (Covid-19 (IgM+IgG+IgA) Microlisa & Covid Kawach IgG Microlisa)

2021

Launched Covid-19 Neutralizing Antibody Microlisa & Covid 19 Ag Microlisa, D-Dimer Microlisa, D-Dimer Quanti Card

2022

Launched Covid 19 Antigen Card, HCV 4th Generation & Syphilis ELISA & Scrub Typhus IgM Quanti Card

2023

Launched Dengue NS1 Ag Self test, Make in India Dengue range (NS1 Ag, IgM & IgG), Thyroid range (T3, T4 & TSH), Vitamin D & Vitamin B12 iCLIA test kits

2024

Launched CLIA Range of Test Kits – Vector Borne (Lepto and Chikungunya), Typhoid, Infectious marker (HIV, HCV and HBV), Hormones, AMH, PCT, Allergen and Ferritin CLIA

iQuant – Impact on Rural Areas

iQuant Introduction

Company Profile